JPMORGAN CHASE & CO - NIVALIS THERAPEUTICS INC ownership

NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 43 filers reported holding NIVALIS THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NIVALIS THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$15,000
-6.2%
6,400
+230.4%
0.00%
Q3 2016$16,000
+1500.0%
1,937
+558.8%
0.00%
Q2 2016$1,000
-99.9%
294
-99.9%
0.00%
Q1 2016$1,207,000
-47.0%
289,394
-1.6%
0.00%
-100.0%
Q4 2015$2,277,000
-47.3%
294,200
-11.6%
0.00%0.0%
Q3 2015$4,319,000
-3.2%
332,971
+13.0%
0.00%0.0%
Q2 2015$4,463,000294,5930.00%
Other shareholders
NIVALIS THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
BVF INC/IL 1,195,013$9,249,0001.58%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,732,412$28,889,0001.17%
TIGER MANAGEMENT L.L.C. 650,915$5,038,0000.65%
RA Capital Management 612,863$4,744,0000.47%
WALL STREET ASSOCIATES 170,400$1,319,0000.37%
Rock Springs Capital Management LP 489,000$3,785,0000.29%
SPHERA FUNDS MANAGEMENT LTD. 231,548$1,792,0000.26%
SABBY MANAGEMENT, LLC 503,595$3,898,0000.21%
KINGDON CAPITAL MANAGEMENT, L.L.C. 399,663$3,093,0000.15%
DAFNA Capital Management LLC 15,000$116,0000.10%
View complete list of NIVALIS THERAPEUTICS INC shareholders